Suitability of paediatric legislation beyond the USA and Europe: a qualitative study on access to paediatric medicines.

ABSTRACT:

Background

Paediatric legislation has contributed to better access to appropriate treatments in the European Union and the USA by requiring paediatric research in return for financial incentives. This study explored whether similar policies could improve access to medicines in other countries.

Methods

We conducted 46 interviews with representatives from healthcare practice, patient organisations and health authorities from six countries (Australia, Brazil, Canada, Kenya, Russia and South Africa) as well as multinational pharmaceutical companies exploring their views regarding access barriers to paediatric medicines. Emphasis was placed on regulation-related barriers and the effect of the COVID-19 pandemic. Where participants were familiar with paediatric legislation, views r

SUBMITTER: Volodina A 

PROVIDER: S-EPMC11816091 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature